Deciphering antiviral efficacy of malaria box compounds against malaria exacerbating viral pathogens- Epstein Barr virus and SARS-CoV-2, an in silico study
In malaria endemic countries, coinfections and cotransmissions of different viral pathogens are widely reported. Prior studies have shown that malaria can trigger the Epstein-Barr virus (EBV) reactivation in the body. Besides, the altered immunity due to malaria could increase susceptibility to acqu...
Saved in:
Main Authors: | Omkar Indari (Author), Ajit Kumar Singh (Author), Deeksha Tiwari (Author), Hem Chandra Jha (Author), Anupam Nath Jha (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?
by: Omkar Indari, et al.
Published: (2021) -
Association between Epstein-Barr virus reactivation and severe malaria in pregnant women living in a malaria-endemic region of Cameroon.
by: Ide Armelle Djuidje Chatue, et al.
Published: (2024) -
In vitro Multistage Malaria Transmission Blocking Activity of Selected Malaria Box Compounds
by: Malebo HM, et al.
Published: (2020) -
Epstein-Barr Virus New Trends
Published: (2021) -
Epstein-Barr virus and skin
by: Martin Sangueza-Acosta, et al.
Published: (2018)